Skip to main content

ANGIODYNAMICS INC

For the period ended Aug 31, 2024. Filed Oct 3, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Aug 31, 2024 · Filed Oct 3, 2024

ANGO$12.07-0.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows (unaudited)

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands of dollars)

Three Months Ended
Aug 31, 2024Aug 31, 2023
Cash flows from operating activities:
Net income (loss)$(12,798)$45,884
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization6,7856,688
Non-cash lease expense494476
Stock based compensation3,2054,144
Gain on disposal of assets—(47,842)
Transaction costs for disposition—(2,427)
Change in fair value of contingent consideration76(130)
Deferred income taxes(339)(11,415)
Change in accounts receivable allowances270(78)
Fixed and intangible asset impairments and disposals2065
Write-off of other assets—869
Other121(9)
Changes in operating assets and liabilities:
Accounts receivable3,7843,157
Inventories(4,053)(4,574)
Prepaid expenses and other(836)(4,168)
Accounts payable, accrued and other liabilities(14,982)(16,539)
Net cash used in operating activities(18,253)(25,899)
Cash flows from investing activities:
Additions to property, plant and equipment(1,092)(791)
Additions to placement and evaluation units(1,313)(767)
Proceeds from sale of assets—100,000
Net cash (used in) provided by investing activities(2,405)98,442
Cash flows from financing activities:
Repayment of long-term debt—(50,000)
Payment of acquisition related contingent consideration—(10,000)
Repurchase of common stock(552)—
Proceeds from exercise of stock options and employee stock purchase plan43410
Net cash used in financing activities(509)(59,590)
Effect of exchange rate changes on cash and cash equivalents11613
Increase (decrease) in cash and cash equivalents(21,051)12,966
Cash and cash equivalents at beginning of period76,05644,620
Cash and cash equivalents at end of period$55,005$57,586
Supplemental disclosure of non-cash investing and financing activities:
Accrual for capital expenditures incurred during the period$(32)$(68)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.